Skip to main content
logo
BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,570.00
+15.00 (0.33%)
At close: Aug 3, 2026

BioNote Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-50,226-87,49855,261-20,497307,798676,601
Depreciation & Amortization
9,5789,2278,1868,2066,4514,106
Loss (Gain) From Sale of Assets
1,6811,671-20.25-265.2-13,412-361,225
Asset Writedown & Restructuring Costs
--4,8358,409--
Loss (Gain) From Sale of Investments
-3,019-1,907-9,3865,0005,150-15,047
Loss (Gain) on Equity Investments
100,660112,7184,98783,791-77,260-
Stock-Based Compensation
364.08264.899.92-1,6371,985
Provision & Write-off of Bad Debts
868.93901.3362.32-2,845-3,5966,827
Other Operating Activities
-30,697-17,992-12,749-82,440-4,08934,137
Change in Accounts Receivable
-6,906-10,089-2,934855.5773,437220,048
Change in Inventory
2,2607,69710,632-436.63-33,543-9,826
Change in Accounts Payable
734.231,622-982.63221.23-4,573-22,140
Change in Other Net Operating Assets
-1,416-2,234-74.32-4,193-8,9011,926
Operating Cash Flow
23,88214,38157,917-4,194249,100537,392
Operating Cash Flow Growth
-49.73%-75.17%---53.65%123.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5,401-8,111-10,462-3,963-42,266-51,425
Sale of Property, Plant & Equipment
7,6847,675727.1894.3649,399174.43
Cash Acquisitions
------6,266
Sale (Purchase) of Intangibles
-102.46-158.52-19.66-579.33-217.44-118.58
Investment in Securities
-41,344-77,416-72,415-477,108-37,446-133,747
Other Investing Activities
0000--
Investing Cash Flow
-39,163-78,011-82,170-481,555-30,530-191,383

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---150,000--
Long-Term Debt Issued
---10.550-
Total Debt Issued
---150,01150-
Short-Term Debt Repaid
----150,000--
Long-Term Debt Repaid
--1,282-1,144-836-415.58-216.76
Total Debt Repaid
-1,340-1,282-1,144-150,836-415.58-216.76
Net Debt Issued (Repaid)
-1,340-1,282-1,144-825.5-365.58-216.76
Issuance of Common Stock
1,498--843.6673,280-
Repurchase of Common Stock
-5,000-5,001-3,108---
Dividends Paid
-20,272-20,272-20,411-49,919-49,959-49,959
Other Financing Activities
-----0-420
Financing Cash Flow
-25,114-26,555-24,663-49,90122,955-50,596

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2,735714.298,8621,97820,930118.56
Net Cash Flow
-37,660-89,470-40,054-533,672262,455295,532

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
18,4826,27047,454-8,156206,834485,966
Free Cash Flow Growth
-46.16%-86.79%---57.44%127.91%
Free Cash Flow Margin
15.09%5.30%46.17%-9.05%43.12%78.09%
Free Cash Flow Per Share
182.8461.95465.43-79.982193.655186.94
Levered Free Cash Flow
13,721-5,92214,076-18,697129,964399,410
Unlevered Free Cash Flow
13,872-5,74314,222-18,321130,017399,438

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
241.08287.11233.55602.8284.4444.25
Cash Income Tax Paid
10,78016,4065,00340,454157,006171,252
Change in Working Capital
-5,328-3,0046,640-3,55326,420190,009